APA (7th ed.) Citation

AC, P., C, C., & PK, S. (2019). A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. ELife, 8, . https://doi.org/10.7554/eLife.50036

Chicago Style (17th ed.) Citation

AC, Palmer, Chidley C, and Sorger PK. "A Curative Combination Cancer Therapy Achieves High Fractional Cell Killing Through Low Cross-resistance and Drug Additivity." ELife 8 (2019). https://doi.org/10.7554/eLife.50036.

MLA (9th ed.) Citation

AC, Palmer, et al. "A Curative Combination Cancer Therapy Achieves High Fractional Cell Killing Through Low Cross-resistance and Drug Additivity." ELife, vol. 8, 2019, https://doi.org/10.7554/eLife.50036.